Mithra Pharmaceuticals S.A.
Mithra Pharmaceuticals S.A. (MITPF) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
MITPF · net income · updated Jun 9, 2026
Core profitability metrics
MITPF · net income · margin · TTM · CAGRNet income was −$173.5M for FY2023 (fiscal year ending 2023-12-31), down 191.0% year-over-year. Net profit margin was -432.1%.
Annual net income history
▸ FMP /income-statement · Annual · MITPF net income history · MITPF profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Mithra Pharmaceuticals S.A. (MITPF) reported net income of −$173.5M for FY2023 (fiscal year ending 2023-12-31), down 191.0% year-over-year. The net profit margin was -432.1% — meaning the company kept $-4.32 of every dollar of revenue as profit.
Mithra Pharmaceuticals S.A. has not yet achieved annual profitability based on available data (12 fiscal years). The company has reported net losses across all available periods.
Mithra Pharmaceuticals S.A.'s net profit margin was -432.1% for FY2023, based on the latest annual results.
Investors sometimes search for "Mithra Pharmaceuticals S.A. net worth" — the company's market capitalization is a separate figure from MITPF net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
MITPF net income · 4 questionsMithra Pharmaceuticals S.A. is not currently profitable on an annual basis. The company reported a net loss of $173.5M for FY2023.
▸ Source: FMP /income-statement · GAAP · Mithra Pharmaceuticals S.A. · Mithra Pharmaceuticals S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026